NEW YORK--(BUSINESS WIRE)--#Acquisition--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Digital World Acquisition Corp. (“Digital World” or the “Company”) (NASDAQ: DWAC) on behalf of Digital World stockholders. Our investigation concerns whether Digital World has violated the federal securities laws and/or engaged in other unlawful business practices. […]
NEW YORK--(BUSINESS WIRE)--#Class--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Shattuck Labs, Inc. (NASDAQ: STTK) on behalf of long-term stockholders following a class action complaint that was filed against Shattuck on February 11, 2022 with a Class Period from October 9, 2020 to November 9, 2021. […]
NEW YORK--(BUSINESS WIRE)--#GATO--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Gatos Silver, Inc. (NYSE: GATO): (a) pursuant and/or traceable to the Registration Statement issued in connection with the Company’s initial public offering (the “IPO” or “Offering”) conducted on or about October 28, 2020; and/or (b) between October […]
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) between April 27, 2017 and February 25, 2022, inclusive (the “Class Period”) of the important May 2, 2022 lead plaintiff deadline. SO WHAT: If you purchased Ericsson securities during the Class Period […]
NEW ORLEANS--(BUSINESS WIRE)--ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until April 4, 2022 to file lead plaintiff applications in a securities class action lawsuit against Electric Last Mile Solutions, Inc. (“ELMS” or the “Company”) f/k/a Forum Merger III Corp. (NasdaqGS: ELMS, ELMSW, FIII, FIIIU, FIIIW), if they purchased the Company’s […]
NEW YORK--(BUSINESS WIRE)--#Biosciences--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pulse Biosciences, Inc. (NASDAQ: PLSE) between January 12, 2021 and February 7, 2022, inclusive (the “Class Period”), of the important April 18, 2022 lead plaintiff deadline. SO WHAT: If you purchased Pulse securities during the Class Period […]
NEW YORK--(BUSINESS WIRE)--#FIXX--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. (NASDAQ: FIXX) between June 10, 2019 and February 18, 2022, inclusive (the “Class Period”), of the important May 24, 2022 lead plaintiff deadline. SO WHAT: If you purchased Homology securities during the Class Period […]
LOS ANGELES--(BUSINESS WIRE)--$LCID #LCID--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lucid Group, Inc. (“Lucid” or “the Company”) (NASDAQ: LCID) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. […]
NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 4, 2022 to file lead plaintiff applications in a securities class action lawsuit against Electric Last Mile Solutions, Inc. (“ELMS” or the “Company”) f/k/a Forum Merger III […]
LOS ANGELES--(BUSINESS WIRE)--$VLTA #VLTA--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Volta Inc. f/k/a Tortoise Acquisition Corp. II (“Volta” or “the Company”) (NYSE: VLTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. […]
Lawyer Monthly is a news website and monthly legal publication with content that is entirely defined by the significant legal news from around the world.
We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you consent to the use of cookies. Privacy PolicyOkI do not consent
